logo-loader
viewClearStar Inc

ClearStar leverages technology for competitive edge in candidate screening sector

Snapshot

  • Provider of candidate background and medical screening services
  • Products include range of mobile applications
  • Did not lose customers during pandemic
Background check

Quick facts: ClearStar Inc

Price: 34.5 GBX

AIM:CLSU
Market: AIM
Market Cap: £12.55 m
Follow

What ClearStar does

ClearStar Inc (LON:CLSU) provides background check and medical screening solutions for employers to give them reliable information when hiring new staff.

The group’s products include;

• ScreenMeNow – a mobile application that allows candidates to conduct their background check using their phone with an e-signature

• ClearID – app designed to validate IDs and provide face-match technology for contract labour

• ClearContact – collates and organises contract worker contact details into a single directory

• ClearMD – drug screening and clinical testing solution that allows candidates to perform their own tests and book their own appointments

 

How it is doing

At the beginning of May, ClearStar said it hadn't lost any customers due to the pandemic, but it noted a reduction in volumes. It also added it was too early to provide guidance for the current period.

Revenue run rate experienced a “significant uptick” from the end of May as the labour market and employers began to slowly recover from the effects of the pandemic.

The firm also launched a coronavirus testing service to support employers with their return-to-work planning and workplace safety.

The service will provide employees with a CRL Clear kit to test blood samples for coronavirus antibodies which will indicate if a person has been previously infected with the disease.

 

What the boss says: Barney Quinn, chairman

"ClearStar has the right solutions to support employers in quickly and securely re-establishing their workforce, which is reflected in the significant uptick in our revenue run rate from the end of May."  

"While we have not yet returned to our pre-COVID-19 revenue run rate, the increase in sales so far is extremely encouraging. As the US economic recovery progresses and our customers are able to resume more normal trading, we expect this growth in our activity to continue."

 

Video

 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of ClearStar Inc named herein, including the promotion by the Company of ClearStar Inc in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

ClearStar Inc joins forces with iCIMS Talent Platform

Bob Vale, chief executive of ClearStar Inc (LON:CLSU), discusses with Proactive Investors their new partnership with iCIMS Inc for the integration of their mobile solutions for background screening and drug testing into the iCIMS Talent Platform - a suite of talent acquisition tools. The...

on 27/6/18

2 min read